Deletion of LPA5104 or XBP-194 in CD8+ T cells has proven effective in enhancing antitumor responses mediated by adoptively transferred T cells in melanoma-bearing mice by inhibiting the excessive generation of toxic LPA and cholesterol, respectively (86, 95). Here, CD8A is linked to melanoma.